TPI
WST icon

Trust Point Inc’s West Pharmaceutical WST Stock Holding History

Trust Point Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Sell
1,062
-1,046
-50% -$320K 0.03% 283
2026
Q1 		$528K Buy
2,108
+1
+0% +$249 0.05% 236
2025
Q4 		$580K Sell
2,107
-176
-8% -$48.1K 0.05% 198
2025
Q3 		$599K Buy
2,283
+278
+14% +$67.6K 0.05% 190
2025
Q2 		$439K Sell
2,005
-783
-28% -$167K 0.04% 212
2025
Q1 		$624K Sell
2,788
-395
-12% -$109K 0.06% 183
2024
Q4 		$1.04M Buy
3,183
+2,427
+321% +$764K 0.07% 147
2024
Q3 		$227K Sell
756
-27
-3% -$8.27K 0.02% 465
2024
Q2 		$258K Sell
783
-83
-10% -$29.3K 0.02% 413
2024
Q1 		$343K Buy
+866
New +$320K 0.03% 372

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Trust Point Inc's WST Position: Q2 2026 in Review

Trust Point Inc reduced its West Pharmaceutical (WST) stake by 50% in Q2 2026, selling an estimated $320K and leaving 1,062 shares worth $381K. The position accounts for 0.03% of the portfolio, ranked #283.

Trust Point Inc first reported a position in WST in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.04M in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Trust Point Inc held 1,062 shares of West Pharmaceutical worth $381K as of Q2 2026.
  • Trust Point Inc sold 1,046 West Pharmaceutical shares in Q2 2026, an estimated $320K.
  • West Pharmaceutical made up 0.03% of Trust Point Inc's portfolio in Q2 2026, its #283 holding.
  • Trust Point Inc first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • Trust Point Inc's West Pharmaceutical position peaked at $1.04M in Q4 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.